Other Commercial Opportunities INJECTABLE ANTIBIOTICS In December <strong>2012</strong>, <strong>Phosphagenics</strong> announced an agreement with Indian company Agila Specialities Private Limited to apply the TPM ® technology to a liquid injectable antibiotic. Agila will be meeting all the costs associated with the commercialisation of the product including all clinical trials required. 20 This represented a totally new area of application of the TPM ® technology and may open the door to a number of other opportunities. TPM ® improves the speed and solubility of the antibiotic powder being prepared prior to injecting into the patient. PHOSPHAGENICS ANNUAL REPORT <strong>2012</strong>
Intellectual Property Title Countries Allowed Countries Pending Expiry A carrier comprising one Australia, Brazil, Japan, Canada, China, Europe, June 2026 or more di and/or mono- (electron transfer agent) phosphate derivatives Mexico, New Zealand, Russia, Singapore, South Africa Hong Kong, India, Israel, , South Korea, USA Alkaloid Formulations Australia, Canada, China, Brazil, Israel, USA March 2025 Europe, Hog Kong, India, Japan, South Korea, Mexico, New Zealand, Russia, Singapore, South Africa Carrier Australia August 2023 Carrier Composition South Africa Australia, Brazil, Canada, China, Europe, India, Israel, Japan, South Korea, Mexico, New Zealand, Russia, Singapore, USA Carrier Composition Australia, Brazil, Canada, China, Europe, India, Israel, Japan, South Korea, Mexico, New Zealand, Russia, Singapore, South Africa, USA Carrier for Enteral Administration Complexes of Phosphate Derivatives December 2030 Feb 2031 Australia, China, Europe, Japan, Mexico, New Zealand, Russia, Singapore, South Africa Brazil, Canada, India, USA August 2025 Australia, Europe Brazil November 2021 Composition Australia, Europe, USA Feb 2031 Compounds Having Lipid Australia, Russia Canada, Europe, Japan, March 2026 Lowering Properties USA Dermal Therapy Australia, Canada, Japan, USA July 2022 Formulations containing Phosphate Derivatives of Electron Transfer Agents Improved Processes for Phosphorylation Australia, Canada, China, Europe, Japan, South Korea, Mexico, USA Australia, Brazil, Canada, Europe, Japan, Mexico, USA Brazil, Hong Kong November 2021 May 2020 New Composition PCT Stage March 2032 Transdermal Delivery Patch Australia, Brazil, Canada, March 2031 China, Europe, India, Israel, Japan, South Korea, Mexico, New Zealand, Russia, Singapore, South Africa, Taiwan, USA Unpublished Applications Formulations Provisional Formulations Provisional 21 INTELLECTUAL PROPERTY